Turnover
≈ €56,000 estimated
The micro format states no turnover.
IMES
Overview
Lifetime
2 annual accounts with figures on one time axispeak €12,131 (2025)
€12,131▲ 113%
peak €9,104 (2025)
€9,104▲ 59.7%
peak €15,304 (2025)
€15,304▲ 147%
€16,810▲ 98.1%
Board1 name since 2024
1 directorZARROUK Mohamed
Documentsfilings and deeds
12-05-202680 days before the deadline
2025micro format
Gross margin from €5,701 to €12,131Result from €5,701 to €9,104Equity from €6,201 to €15,304Debts from €8,485 to €16,810
Key points
from the 2025 annual accountsChecked score
90
Excellent
Financially stronger than 58% of micro companies in head offices and management consultancy (NACE 70)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.1% across 48,570 companies (NACE 70, micro).
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
01-2026: 0.1%lowest value
02-2026: 0.1%● unchanged vs 01-2026lowest value
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.2%▲ +0.1 percentage points vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.2%● unchanged vs 06-2026
08-2026: 0.2%● unchanged vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026highest value
10-2026: 0.2%● unchanged vs 09-2026
11-2026: 0.2%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Founded in 2024
Liquidity: current ratio 1.91, cash €790
lowers risk
Sector: Activities of head offices; management consultancy activities (NACE 70)
Size: total assets €32,114
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro). It does better than 44% of them on solvency, 11% on liquidity, 84% on profitability and 93% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 11,279 companies had the same profile as IMES has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of IMES itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,279 companies, not a prediction for IMES. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.91 (1.73 in 2024), above the usual 1.5. Short-term debt is 52.3% and cash 2.5% of total assets. However, 52.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-05-2026, 80 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
80 days early
2024
8 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 2 accounts on average 44 days before the deadline. In the sector (NACE 70), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1017465563
Incorporation
Founding capital of €500 · Founder: ZARROUK Mohamed (constituant) · Appointment: ZARROUK Mohamed (director) · published on 18-12-2024 · Gazette deed
First establishment
Joseph Claesstraat 43, Sint-Gillis (bij-Brussel)
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| IMES Sint-Gillis (bij-Brussel) | €32,114 | €12,131 | 47.7% | - |
| WHY NOT CONSULTING Schaerbeek | €33,994 | €10,495 | 28.0% | - |
| Vistuon Woluwe-Saint-Lambert | €35,336 | €11,656 | 59.2% | - |
| HANNE HONORÉ Uccle | €37,566 | €10,575 | 46.3% | - |
| MSB Technical Projects Anderlecht | €25,881 | €13,734 | 39.7% | - |
| DBDG CONSULTING Gerpinnes | €29,909 | €12,476 | 32.5% | - |
| DACA CONSULTING Sint-Niklaas | €31,338 | €12,760 | 28.8% | - |
These companies have the same main activity as IMES: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €25,900 and €37,600, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 16-12-2024Normal situation
- Activity
- Business and other management consultancyNACE 70200and 1 other
- Establishment unit
- 2.372.902.5851060 Sint-Gillis (bij-Brussel), since 16-12-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 31-10-2025
Annual accounts 2025
- €12,131▲ 113%
- €9,104▲ 59.7%
- €15,304▲ 147%
- €32,114▲ 119%
- Filing
- Filed on 12-05-2026, 80 days before the end of the filing period
Insights on IMES
IMES has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15,304 and a net result of €9,104.
Its solvency ranks better than 43% of 39,368 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 12-05-2026, 80 days before the deadline€12,131
▲ 113%
€11,744
▲ 106%
€9,104
▲ 59.7%
€15,304
▲ 147%
47.7%
▲ 5.4 percentage points
1.91
▲ 0.18
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €56,000. Estimated: probably between €26,000 and €110,000.
Amounts without an identifiable currency are taken as euros.
Balance sheet
balance sheet total €32,114 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
47.7%
Higher than 43% of 39,368 companies in 2025.
1.91
Higher than 47% of 38,051 companies in 2025.
28.3%
Higher than 69% of 38,523 companies in 2025.
IMES
Middle half of the sector
80% of the sector
Micro accounts in head offices and management consultancy (NACE 70)
Net result: middle half · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
32,114 | 14,685 | |
29/58 |
32,114 | 14,685 | |
40/41 |
31,325 | 13,776 | |
40 |
30,395 | 13,776 | |
41 |
929 | - | |
54/58 |
790 | 909 | |
| Balance sheet: equity and liabilities | |||
10/49 |
32,114 | 14,685 | |
10/15 |
15,304 | 6,201 | |
10/11 |
500 | 500 | |
14 |
14,804 | 5,701 | |
17/49 |
16,810 | 8,485 | |
42/48 |
16,810 | 8,485 | |
44 |
3,458 | 6,095 | |
440/4 |
3,458 | 6,095 | |
45 |
8,418 | 1,980 | |
450/3 |
8,218 | 1,980 | |
454/9 |
200 | - | |
47/48 |
4,934 | 409 | |
| Income statement | |||
9900 |
12,131 | 5,701 | |
640/8 |
387 | - | |
9901 |
11,744 | 5,701 | |
65/66B |
40 | - | |
65 |
40 | - | |
9903 |
11,704 | 5,701 | |
67/77 |
2,600 | - | |
9904 |
9,104 | 5,701 | |
9905 |
9,104 | 5,701 | |
| Appropriation of the result | |||
9906 |
14,804 | 5,701 | |
14P |
5,701 | - | |
| Document | |||
The notes to these accounts have 1 item. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 12-05-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| -120 | - | ||
| 15,304 | 6,201 | ||
| 47.7% | 42.2% | ||
| 1.91 | 1.73 | ||
| 1.10 | 1.37 | ||
| 59.5% | 91.9% | ||
| 28.3% | 38.8% |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Insights on IMES
The operating result for 2025 is 106% higher than in 2024.
Debt's share of the balance-sheet total falls from 57.8% to 52.3%. Equity and debt are higher.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
since 16-12-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 12-05-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 18-12-2024
Mandates through the years
1 name, the dashed line is todayZARROUK Mohamed
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- ZARROUK Mohamed
- Director (not named in the articles), from 16-12-2024 to date
Control
Founder
ZARROUK Mohamed
This company
IMES
Equity €15,304
Profit €9,104 in 2025
Capital
- Contribution
- €500
- Source
- deed of 18-12-2024
Articles of association
deed of 18-12-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Article 9, excédent attribué par voie du sort par organe d'administration à défaut d'accord”
- Share issue ruleThe articles set how and by whom new shares are issued.
- “Peuvent être souscrites par personnes à cession libre conformément à la loi ou tiers moyennant agrément de la moitié au moins des…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 17:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Founder
At incorporation
deed of 18-12-2024 ↗
- ZARROUK Mohamed sole founder · 100% at incorporation
Network & group
No group
IMES has no parent and no holdings in its annual accounts. ZARROUK Mohamed is the only director. IMES shares no director with another company.
At the same address
Joseph Claesstraat 43, 1060 Saint-Gilles · 7 other companies| Rǎdoi, Alexandru (sole trader)
establishment since 17-01-2025 |
founded in 2025 1018.844.349 |
| Arbo Eco Cama
registered office since 22-11-2024 |
founded in 2024 1016.529.613 |
| Zarrouk, Mohamed (sole trader)
establishment since 01-07-2024 |
founded in 2024 1011.941.117 |
| Fortu, Gabriel (sole trader)
establishment since 15-03-2021 |
founded in 2021 0765.278.332 |
| Chourak, Hicham (sole trader)
establishment since 05-01-2019 |
founded in 2019 0716.884.339 |
| Raszkiewicz, Mariusz (sole trader)
establishment since 01-08-2008 |
founded in 2008 0899.747.155 |
| Association des copropriétaires à Saint-Gilles rue Joseph Claes 43
registered office since 31-10-1975 |
founded in 1975 0783.658.050 |
Timeline
Timeline
5 events since 2024Filings
Establishments
202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 80 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:1017465563
Annual accounts 2024 filed NBBmicro format · 8 days before the deadline
2024
IncorporationFounding capital of €500 · Founder: ZARROUK Mohamed (constituant) · Appointment: ZARROUK Mohamed (director) · published on 18-12-20245 points ▸
- Founder, ZARROUK Mohamed (constituant)
- Founding capital, €500
- 100 shares
- Registered office clause, Rue Joseph Claesstraat 43/0002, 1060 Saint-Gilles
- Director appointment, ZARROUK Mohamed (director (not named in the articles))
- The deed holds 2 more points.
First establishment Joseph Claesstraat 43, Sint-Gillis (bij-Brussel)
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 1017.465.563
- VAT number
- BE 1017.465.563
- Peppol ID
- 0208:1017465563
- Other Peppol ID
- 9925:BE1017465563
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 16-12-2024
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 17:00deed of 18-12-2024 (in French)
- Peppol
- Reachable since 31-10-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- IMES in French
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 18-12-2024 (in French)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Région de Bruxelles-Capitale”deed of 18-12-2024 (in French)
Activities
NACEBEL 202570200
Business and other management consultancy main activity
Codes under NACEBEL 2008
70220
Business consulting main activity
86909
Human health activities
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “L’exploitation d’une ou de plusieurs pharmacies,industrielles ou non; Les activités de pharmacien biologiste au sein de cliniques et…”deed of 18-12-2024 (in French)
10 activities
- L’exploitation d’une ou de plusieurs pharmacies,industrielles ou non ;
- Les activités de pharmacien biologiste au sein de cliniques et hôpitaux ;
- Le commerce en gros et en détail,l’achat et la vente ainsi que la recherche,le développement,la commercialisation,la préparation,le traitement et la fabrication de médicaments en tous genres,produits chimiques,pharmaceutiques,phytopharmaceutiques,parapharmaceutiques,homéopathiques et hygiéniques,pesticides et spécialités,cosmétiques comprises,parfumerie,alimentation pour nourrissons et enfants ainsi que diététique et naturelle et articles de droguerie et de manière générale de tous articles chirurgicaux,médicaux et autres,qu’ils soient destinés aux particuliers,à l'équipement des cabinets médicaux et dentaires,aux établissements hospitaliers,aux laboratoires,à l'industrie.
- Le commerce en gros et en détail,l’achat et la vente,la production et la réparation de toutes espèces de machines,appareils et instruments médicaux ou chirurgicaux,appareils optiques et auditifs,lunettes de soleil,articles,produits,appareils et objets en tous genres relatifs à la bandagisterie et l’orthopédie ainsi qu’à l’exécution d’analyses cliniques,produits et instruments vétérinaires,y compris les articles pour petits animaux domestiques et de basse-cour.
- L’analyse des aliments,eaux potables et tous produits ou compositions biologiquement actives.
- Toute activité commerciale relative aux soins de santé dans leur acception la plus large.
- Toutes les activités liées au marketing digital,au management et au nettoyage dans leur sens le plus large.
- La réalisation de toutes opérations foncières et immobilières et notamment l'achat,la vente,l'échange,la mise en valeur,le lotissement,la construction,la reconstruction,la démolition,la transformation,l'exploitation et la location de tous immeubles bâtis ou non bâtis,meublés ou non.
- La réalisation de toutes opérations relatives à l'activité de courtier en vente d'immeubles,de marchand de biens,la promotion immobilière,
- L’activité d'administrateur de biens et la prise et la remise de fonds de commerce.
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Joseph Claesstraat 43 registered office 1060 Sint-Gillis (bij-Brussel) 47730 Retail sale of pharmaceutical products | 16-12-2024 | 2.372.902.585 |
Buildings and parcels at the address
- Ground area
- 185 m²
- Buildings
- 78 m²
- Volume, LiDAR
- 1,156 m³
- Tallest building
- 18.7 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 21562A0342/00T011 | 185 m² | 1 · 78 m² | 18.7 m · 6 |